Role of oxidative stress and antioxidants in daily nutrition and human health

Nutrition

Volumn 33, Issue , 2017, Pages 311-321

  Bjørklund, Geir ^a   Chirumbolo, Salvatore ^b  

^a Council for Nutritional and Environmental Medicine ^*  (Norway)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

Antioxidant effect; Metabolic syndrome; Obesity; Oxidative stress; Phytochemicals; Reactive oxygen species

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; FLAVANOID; LEPTIN; POLYPHENOL; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; RETINOL; TUMOR NECROSIS FACTOR; PLANT MEDICINAL PRODUCT;

ADIPOCYTE; ANTIOXIDANT ACTIVITY; BIOAVAILABILITY; CARDIOVASCULAR DISEASE; CELL FUNCTION; CELL SURVIVAL; CELLULAR STRESS RESPONSE; CELLULAR STRESS SIGNAL; CYTOKINE PRODUCTION; CYTOKINESIS; DIETARY INTAKE; DISEASE COURSE; ENDOPLASMIC RETICULUM; EXERCISE; HUMAN; IMMUNE SYSTEM; IN VITRO STUDY; MEDIATOR RELEASE; METABOLIC SYNDROME X; MITOCHONDRION; MOLECULAR INTERACTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRITIONAL HEALTH; OBESITY; OXIDATIVE STRESS; PHYSICAL ACTIVITY; PHYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REDOX STRESS; REVIEW; SIGNAL TRANSDUCTION; VITAMIN SUPPLEMENTATION; WHEAT; WHITE ADIPOSE TISSUE; ANIMAL; CHRONIC DISEASE; EVIDENCE BASED MEDICINE; HEALTHY DIET; NUTRITIONAL STATUS; PATIENT COMPLIANCE; PERSONALIZED MEDICINE;

ANIMALS; ANTIOXIDANTS; CHRONIC DISEASE; EVIDENCE-BASED MEDICINE; HEALTHY DIET; HUMANS; NUTRITIONAL STATUS; OXIDATIVE STRESS; PATIENT COMPLIANCE; PHYTOCHEMICALS; PRECISION MEDICINE;

EID: 85003422073     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2016.07.018     Document Type: Review

References (190)

1. [1] Withrow, D., Alter, D.A., The economic burden of obesity worldwide: a systematic review of the direct costs of obesity. Obes Rev 12 (2011), 131–141.
2. [2] Nettleton, J.A., Jebb, S., Risérus, U., Koletzko, B., Fleming, J., Role of dietary fats in the prevention and treatment of the metabolic syndrome. Ann Nutr Metab 64 (2014), 167–178.
3. [3] Amihăesei, I.C., Chelaru, L., Metabolic syndrome a widespread threatening condition; risk factors, diagnostic criteria, therapeutic options, prevention and controversies: an overview. Rev Med Chir Soc Med Nat Iasi 118 (2014), 896–900.
4. [4] Müller-Riemenschneider, F., Reinhold, T., Berghöfer, A., Willich, S.N., Health-economic burden of obesity in Europe. Eur J Epidemiol 23 (2008), 499–509.
5. [5] Latnovic, L., Rodriguez Cabrera, L., Public health strategy against overweight and obesity in Mexico's National Agreement for Nutritional Health. Int J Obes Suppl 3:suppl 1 (2013), S12–S14.
6. [6] Rupasinghe, H.P., Sekhon-Loodu, S., Mantso, T., Panayiotidis, M.I., Phytochemicals in regulating fatty acid β-oxidation: potential underlying mechanisms and their involvement in obesity and weight loss. Pharmacol Ther 165 (2016), 153–163.
7. [7] Popkin, B.M., Nutrition transition and the global diabetes epidemic. Curr Diab Rep, 15, 2015, 64.
8. [8] Borchers, A.T., Keen, C.L., Gershwin, M.E., The basis of structure/function claims of nutraceuticals. [E-pub ahead of print] Clin Rev Allergy Immunol, 2016 Apr 28.
9. [9] Chudasama, R.K., Eshwar, T.K., Eshwar, S.T., Thakkar, D., Obesity and overweight prevalence among school children and adolescents aged 8-18 years in Rajkot, Gujarat. [E-pub ahead of print] Indian Pediatr, 2016 Jun 1.
10. [10] Berkowitz, S.A., Fabreau, G.E., Raghavan, S., Kentoffio, K., Chang, Y., He, W., et al. Risk of developing diabetes among refugees and immigrants: a longitudinal analysis. [E-pub ahead of print] J Community Health, 2016 Jun 30.
11. [11] Gupta, N., Goel, K., Shah, P., Misra, A., Childhood obesity in developing countries:epidemiology, determinants, and prevention. Endocr Rev 33 (2012), 48–70.
12. [12] Hosseini, B., Saedisomeolia, A., Allman-Farinelli, M., Association between antioxidant intake/status and obesity: a systematic review of observational studies. [E-pub ahead of print] Biol Trace Elem Res, 2016 Jun 22.
13. [13] Galan, P., Viteri, F.E., Bertrais, S., Czernichow, S., Faure, H., Arnaud, J., et al. Serum concentrations of beta-carotene, vitamins C and E, zinc and selenium are influenced by sex, age, diet, smoking status, alcohol consumption and corpulence in a general French adult population. Eur J Clin Nutr 59 (2005), 1181–1190.
14. [14] Wallström, P., Wirfält, E., Lahmann, P.H., Gullberg, B., Janzon, L., Berglund, G., Serum concentrations of beta-carotene and alpha-tocopherol are associated with diet, smoking, and general and central adiposity. Am J Clin Nutr 73 (2001), 777–785.
15. [15] Wang, T., Si, Y., Shirihai, O.S., Si, H., Schultz, V., Corkey, R.F., et al. Respiration in adipocytes is inhibited by reactive oxygen species. Obesity (Silver Spring) 18 (2010), 1493–1502.
16. [16] Netzer, N., Gatterer, H., Faulhaber, M., Burtscher, M., Pramsohler, S., Pesta, D., Hypoxia, oxidative stress and fat. Biomolecules 5 (2015), 1143–1150.
17. [17] Rupérez, A.I., Gil, A., Aguilera, C.M., Genetics of oxidative stress in obesity. Int J Mol Sci 15 (2014), 3118–3144.
18. [18] Weng, S.W., Lin, T.K., Wang, P.W., Chen, S.D., Chuang, Y.C., Liou, C.W., Single nucleotide polymorphisms in the mitochondrial control region are associated with metabolic phenotypes and oxidative stress. Gene 531 (2013), 370–376.
19. [19] Verdile, G., Keane, K.N., Cruzat, V.F., Medic, S., Sabale, M., Rowles, J., et al. Inflammation and oxidative stress: the molecular connectivity between insulin resistance, obesity, and Alzheimer's disease. Mediators Inflamm, 2015, 2015, 105828.
20. [20] Lu, Y.S., Huang, B.T., Huang, Y.X., Reactive oxygen species formation and apoptosis in human peripheral blood mononuclear cell induced by 900 MHz mobile phone radiation. Oxid Med Cell Longev, 2012, 2012, 740280.
21. [21] Pall, M.L., Electromagnetic fields act via activation of voltage-gated calcium channels to produce beneficial or adverse effects. J Cell Mol Med 17 (2013), 958–965.
22. [22] Fulda, S., Gorman, A.M., Hori, O., Samali, A., Cellular stress responses: cell survival and cell death. Int J Cell Biol, 2010, 2010, 214074.
23. [23] Kültz, D., Molecular and evolutionary basis of the cellular stress response. Annu Rev Physiol 67 (2005), 225–257.
24. [24] Söti, C., Csermely, P., Protein stress and stress proteins: Implications in aging and disease. J Biosci 32 (2007), 511–515.
25. [25] Behl, T., Kaur, I., Kotwani, A., Implication of oxidative stress in progression of diabetic retinopathy. Surv Ophthalmol 61 (2016), 187–196.
26. [26] Luque-Contreras, D., Carvajal, K., Toral-Rios, D., Franco-Bocanegra, D., Campos-Peña, V., Oxidative stress and metabolic syndrome: cause or consequence of Alzheimer's disease?. Oxid Med Cell Longev, 2014, 2014, 497802.
27. [27] Nishikawa, T., Araki, E., Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications. Antioxid Redox Signal 9 (2007), 343–353.
28. [28] Chattopadhyay, M., Khemka, V.K., Chatterjee, G., Ganguly, A., Mukhopadhyay, S., Chakrabarti, S., Enhanced ROS production and oxidative damage in subcutaneous white adipose tissue mitochondria in obese and type 2 diabetes subjects. Mol Cell Biochem 399 (2015), 95–103.
29. [29] Le Lay, S., Simard, G., Martinez, M.C., Andriantsitohaina, R., Oxidative stress and metabolic pathologies: from an adipocentric point of view. Oxid Med Cell Longev, 2014, 2014, 908539.
30. [30] Singh, P.P., Mahadi, F., Roy, A., Sharma, P., Reactive oxygen species, reactive nitrogen species and antioxidants in etiopathogenesis of diabetes mellitus type-2. Indian J Clin Biochem 24 (2009), 324–342.
31. [31] Nicolson, G.L., Metabolic syndrome and mitochondrial function: molecular replacement and antioxidant supplements to prevent membrane peroxidation and restore mitochondrial function. J Cell Biochem 100 (2007), 1352–1369.
32. [32] Apel, K., Hirt, H., Reactive oxygen species: metabolism, oxidative stress, and signal transduction. Annu Rev Plant Biol 55 (2004), 373–399.
33. [33] Thannickal, V.J., Fanburg, B.L., Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 279 (2000), L1005–L1028.
34. [34] Keane, K.N., Cruzat, V.F., Carlessi, R., de Bittencourt, P.I. Jr., Newsholme, P., Molecular events linking oxidative stress and inflammation to insulin resistance and β-cell dysfunction. Oxid Med Cell Longev, 2015, 2015, 181643.
35. [35] Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114 (2004), 1752–1761.
36. [36] Holvoet, P., Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease. Verh K Acad Geneeskd Belg 70 (2008), 193–219.
37. [37] Matsuda, M., Shimomura, I., Increased oxidative stress in obesity: implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer. Obes Res Clin Pract 7 (2013), e330–e341.
38. [38] Russell, E.G., Cotter, T.G., New insights into the role of reactive oxygen species (ROS) in cellular-signal transduction processes. Int Rev Cell Mol Biol 319 (2015), 221–254.
39. [39] Syed Mortadza, S.A., Wang, L., Li, D., Jiang, L.H., TRPM2 Channel-mediated ROS-sensitive Ca(2+) signaling mechanisms in immune cells. Front Immunol, 6, 2015, 407.
40. [40] Nazıroğlu, M., TRPM2 cation channels, oxidative stress and neurological diseases: where are we now?. Neurochem Res 36 (2011), 355–366.
41. [41] Ye, M., Yang, W., Ainscough, J.F., Hu, X.P., Li, X., Sedo, A., et al. TRPM2 channel deficiency prevents delayed cytosolic Zn2+ accumulation and CA1 pyramidal neuronal death after transient global ischemia. Cell Death Dis, 5, 2014, e1541.
42. [42] Knowles, H., Li, Y., Perraud, A.L., The TRPM2 ion channel, an oxidative stress and metabolic sensor regulating innate immunity and inflammation. Immunol Res 55 (2013), 241–248.
43. [43] Hotamisligil, G.S., Arner, P., Caro, J.F., Atkinson, R.L., Spiegelman, B.M., Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95 (1995), 2409–2415.
44. [44] Kern, P.A., Saghizadeh, M., Ong, J.M., Bosch, R.J., Deem, R., Simsolo, R.B., The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 95 (1995), 2111–2119.
45. 2 govern local inflammatory tone in obese fat. J Immunol 189 (2012), 2597–2605.
46. [46] Muñoz, A., Costa, M., Nutritionally mediated oxidative stress and inflammation. Oxid Med Cell Longev, 2013, 2013, 610950.
47. [47] Olli, K., Lahtinen, S., Rautonen, N., Tiihonen, K., Betaine reduces the expression of inflammatory adipokines caused by hypoxia in human adipocytes. Br J Nutr 109 (2013), 43–49.
48. [48] Chirumbolo, S., Franceschetti, G., Zoico, E., Bambace, C., Cominacini, L., Zamboni, M., LPS response pattern of inflammatory adipokines in an in vitro 3 T3-L1 murine adipocyte model. Inflamm Res 63 (2014), 495–507.
49. [49] Goldfeld, A.E., Doyle, C., Maniatis, T., Human tumor necrosis factor alpha gene regulation by virus and lipopolysaccharide. Proc Natl Acad Sci U S A 87 (1990), 9769–9773.
50. [50] Kwon, J., Chung, I.Y., Benveniste, E.N., Cloning and sequence analysis of the rat tumor necrosis factor-encoding genes. Gene 132 (1993), 227–236.
51. [51] Kabe, Y., Ando, K., Hirao, S., Yoshida, M., Handa, H., Redox regulation of NF-kappaB activation: distinct redox regulation between the cytoplasm and the nucleus. Antioxid Redox Signal 7 (2005), 395–403.
52. [52] Pantano, C., Reynaert, N.L., van der Vliet, A., Janssen-Heininger, Y.M., Redox-sensitive kinases of the nuclear factor-kappaB signaling pathway. Antioxid Redox Signal 8 (2006), 1791–1806.
53. [53] Janssen-Heininger, Y.M., Poynter, M.E., Aesif, S.W., Pantano, C., Ather, J.L., Reynaert, N.L., et al. Nuclear factor kappaB, airway epithelium, and asthma: Avenues for redox control. Proc Am Thorac Soc 6 (2009), 249–255.
54. [54] Adcock, I.M., Caramori, G., Cross-talk between pro-inflammatory transcription factors and glucocorticoids. Immunol Cell Biol 79 (2001), 376–384.
55. [55] Barnes, P.J., Transcription factors in airway diseases. Lab Invest 86 (2006), 867–872.
56. [56] Gechev, T.S., Van Breusegem, F., Stone, J.M., Denev, I., Laloi, C., Reactive oxygen species as signals that modulate plant stress responses and programmed cell death. Bioessays 28 (2006), 1091–1101.
57. [57] D'Autréaux, B., Toledano, M.B., ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 8 (2007), 813–824.
58. [58] Juránek, I., Nikitovic, D., Kouretas, D., Hayes, A.W., Tsatsakis, A.M., Biological importance of reactive oxygen species in relation to difficulties of treating pathologies involving oxidative stress by exogenous antioxidants. Food Chem Toxicol 61 (2013), 240–247.
59. [59] Kardeh, S., Ashkani-Esfahani, S., Alizadeh, A.M., Paradoxical action of reactive oxygen species in creation and therapy of cancer. Eur J Pharmacol 735 (2014), 150–168.
60. [60] Vieira-Potter, V.J., Inflammation and macrophage modulation in adipose tissues. Cell Microbiol 16 (2014), 1484–1492.
61. [61] Malandrino, M.I., Fucho, R., Weber, M., Calderon-Dominguez, M., Mir, J.F., Valcarcel, L., et al. Enhanced fatty acid oxidation in adipocytes and macrophages reduces lipid-induced triglyceride accumulation and inflammation. Am J Physiol Endocrinol Metab 308 (2015), E756–E769.
62. [62] Palomba, L., Silvestri, C., Imperatore, R., Morello, G., Piscitelli, F., Martella, A., et al. Negative regulation of leptin-induced reactive oxygen species (ROS) formation by cannabinoid CB1 receptor activation in hypothalamic neurons. J Biol Chem 290 (2015), 13669–13677.
63. [63] Romacho, T., Elsen, M., Röhrborn, D., Eckel, J., Adipose tissue and its role in organ crosstalk. Acta Physiol (Oxf) 21 (2014), 733–753.
64. [64] Diano, S., Role of reactive oxygen species in hypothalamic regulation of energy metabolism. Endocrinol Metab (Seoul) 28 (2013), 3–5.
65. [65] Predonzani, A., Calì, B., Agnellini, A.H., Molon, B., Spotlights on immunological effects of reactive nitrogen species: when inflammation says nitric oxide. World J Exp Med 5 (2015), 64–76.
66. [66] Luna-López, A., González-Puertos, V.Y., López-Diazguerrero, N.E., Königsberg, M., New considerations on hormetic response against oxidative stress. J Cell Commun Signal 8 (2014), 323–331.
67. [67] Gupta, C., Prakash, D., Phytonutrients as therapeutic agents. J Complement Integr Med 11 (2014), 151–169.
68. [68] Zhou, S.S., Li, D., Chen, N.N., Zhou, Y., Vitamin paradox in obesity: deficiency or excess?. World J Diabetes 6 (2015), 1158–1167.
69. [69] Baltaci, D., Kutlucan, A., Turker, Y., Yilmaz, A., Karacam, S., Deler, H., et al. Association of vitamin B12 with obesity, overweight, insulin resistance and metabolic syndrome, and body fat composition; primary care-based study. Med Glas (Zenica) 10 (2013), 203–210.
70. [70] Foss, Y.J., Vitamin D deficiency is the cause of common obesity. Med Hypotheses 72 (2009), 314–321.
71. [71] Singh, R.B., Beegom, R., Rastogi, S.S., Gaoli, Z., Shoumin, Z., Association of low plasma concentrations of antioxidant vitamins, magnesium and zinc with high body fat per cent measured by bioelectrical impedance analysis in Indian men. Magnes Res 11 (1998), 3–10.
72. [72] Noy, N., Vitamin A in regulation of insulin responsiveness: mini review. Proc Nutr Soc 75 (2016), 212–215.
73. [73] Berry, D.C., Noy, N., Signaling by vitamin A and retinol-binding protein in regulation of insulin responses and lipid homeostasis. Biochim Biophys Acta 1821 (2012), 168–176.
74. [74] Alcalá, M., Sánchez-Vera, I., Sevillano, J., Herrero, L., Serra, D., Ramos, M.P., et al. Vitamin E reduces adipose tissue fibrosis, inflammation, and oxidative stress and improves metabolic profile in obesity. Obesity (Silver Spring) 23 (2015), 1598–1606.
75. [75] Alizadeh, M., Safaeiyan, A., Ostadrahimi, A., Estakhri, R., Daneghian, S., Ghaffari, A., et al. Effect of L-arginine and selenium added to a hypocaloric diet enriched with legumes on cardiovascular disease risk factors in women with central obesity: a randomized, double-blind, placebo-controlled trial. Ann Nutr Metab 60 (2012), 157–168.
76. [76] Garcia-Diaz, D.F., Lopez-Legarrea, P., Quintero, P., Martinez, J.A., Vitamin C in the treatment and/or prevention of obesity. J Nutr Sci Vitaminol (Tokyo) 60 (2014), 367–379.
77. [77] Garcia-Diaz, D.F., Campion, J., Arellano, A.V., Milagro, F.I., Moreno-Aliaga, M.J., Martinez, J.A., Fat intake leads to differential response of rat adipocytes to glucose, insulin and ascorbic acid. Exp Biol Med (Maywood) 237 (2012), 407–416.
78. [78] Garcia-Diaz, D.F., Campion, J., Milagro, F.I., Boque, N., Moreno-Aliaga, M.J., Martinez, J.A., Vitamin C inhibits leptin secretion and some glucose/lipid metabolic pathways in primary rat adipocytes. J Mol Endocrinol 45 (2010), 33–43.
79. [79] Lane, M.L., Vesely, D.L., Reduction of leptin levels by four cardiac hormones: implications for hypertension in obesity. Exp Ther Med 6 (2013), 611–615.
80. [80] Montague, C.T., Farooqi, I.S., Whitehead, J.P., Soos, M.A., Rau, H., Wareham, N.J., et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387 (1997), 903–908.
81. [81] Hammerling, U., Retinol as electron carrier in redox signaling, a new frontier in vitamin A research. Hepatobiliary Surg Nutr 5 (2016), 15–28.
82. [82] Acin-Perez, R., Hoyos, B., Zhao, F., Vinogradov, V., Fischman, D.A., Harris, R.A., et al. Control of oxidative phosphorylation by vitamin A illuminates a fundamental role in mitochondrial energy homoeostasis. FASEB J 24 (2010), 627–636.
83. [83] Ibrahim, W.H., Bhagavan, H.N., Chopra, R.K., Chow, C.K., Dietary coenzyme Q10 and vitamin E alter the status of these compounds in rat tissues and mitochondria. J Nutr 130 (2000), 2343–2348.
84. [84] KC, S., Cárcamo, J.M., Golde, D.W., Vitamin C enters mitochondria via facilitative glucose transporter 1 (Glut1) and confers mitochondrial protection against oxidative injury. FASEB J 19 (2005), 1657–1667.
85. [85] Bonomini, F., Rodella, L.F., Rezzani, R., Metabolic syndrome, aging and involvement of oxidative stress. Aging Dis 6 (2015), 109–120.
86. [86] Be Tu, P.T., Chompoo, J., Tawata, S., Hispidin and related herbal compounds from Alpinia zerumbet inhibit both PAK1-dependent melanogenesis in melanocytes and reactive oxygen species (ROS) production in adipocytes. Drug Discov Ther 9 (2015), 197–204.
87. [87] Anjaneyulu, M., Chopra, K., Quercetin, an anti-oxidant bioflavonoid, attenuates diabetic nephropathy in rats. Clin Exp Pharmacol Physiol 31 (2004), 244–248.
88. [88] Devi, K.P., Malar, D.S., Nabavi, S.F., Sureda, A., Xiao, J., Nabavi, S.M., et al. Kaempferol and inflammation: from chemistry to medicine. Pharmacol Res 99 (2015), 1–10.
89. [89] Heim, K.E., Tagliaferro, A.R., Bobilya, D.J., Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships. J Nutr Biochem 13 (2002), 572–584.
90. [90] Lin, L., Pang, W., Chen, K., Wang, F., Gengler, J., Sun, Y., et al. Adipocyte expression of PU.1 transcription factor causes insulin resistance through upregulation of inflammatory cytokine gene expression and ROS production. Am J Physiol Endocrinol Metab 302 (2012), E1550–E1559.
91. [91] Goebl, M.K., The PU.1 transcription factor is the product of the putative oncogene Spi-1. Cell 61 (1990), 1165–1166.
92. [92] Hromas, R., Orazi, A., Neiman, R.S., Maki, R., Van Beveran, C., Moore, J., et al. Hematopoietic lineage- and stage-restricted expression of the ETS oncogene family member PU.1. Blood 82 (1993), 2998–3004.
93. [93] Wang, F., Tong, Q., Transcription factor PU.1 is expressed in white adipose and inhibits adipocyte differentiation. Am J Physiol Cell Physiol 295 (2008), C213–C220.
94. [94] Ji, S., Li, W., Bao, L., Han, P., Yang, W., Ma, L., et al. PU.1 promotes miR-191 to inhibit adipogenesis in 3 T3-L1 preadipocytes. Biochem Biophys Res Commun 451 (2014), 329–333.
95. [95] Kulyté, A., Belarbi, Y., Lorente-Cebrián, S., Bambace, C., Arner, E., Daub, C.O., et al. Additive effects of microRNAs and transcription factors on CCL2 production in human white adipose tissue. Diabetes 63 (2014), 1248–1258.
96. [96] Dali-Youcef, N., Mecili, M., Ricci, R., Andrès, E., Metabolic inflammation: connecting obesity and insulin resistance. Ann Med 45 (2013), 242–253.
97. [97] Vielma, S.A., Klein, R.L., Levingston, C.A., Young, M.R., Adipocytes as immune regulatory cells. Int Immunopharmacol 16 (2013), 224–231.
98. [98] Mraz, M., Haluzik, M., The role of adipose tissue immune cells in obesity and low-grade inflammation. J Endocrinol 222 (2014), R113–R127.
99. [99] Ferrante, A.W. Jr., The immune cells in adipose tissue. Diabetes Obes Metab 15:suppl 3 (2013), 34–38.
100. [100] Huh, J.Y., Park, Y.J., Ham, M., Kim, J.B., Crosstalk between adipocytes and immune cells in adipose tissue inflammation and metabolic dysregulation in obesity. Mol Cells 37 (2014), 365–371.
101. [101] Pajares, M., Jiménez-Moreno, N., Dias, I.H., Debelec, B., Vucetic, M., Fladmark, K.E., et al. Redox control of protein degradation. Redox Biol 6 (2015), 409–420.
102. [102] Sekine, S., Ichijo, H., Mitochondrial proteolysis: its emerging roles in stress responses. Biochim Biophys Acta 1850 (2015), 274–280.
103. [103] Navarro-Yepes, J., Burns, M., Anandhan, A., Khalimonchuk, O., del Razo, L.M., Quintanilla-Vega, B., et al. Oxidative stress, redox signaling, and autophagy: cell death versus survival. Antioxid Redox Signal 21 (2014), 66–85.
104. [104] Santilli, F., Guagnano, M.T., Vazzana, N., La Barba, S., Davi, G., Oxidative stress drivers and modulators in obesity and cardiovascular disease: from biomarkers to therapeutic approach. Curr Med Chem 22 (2015), 582–595.
105. [105] Maachi, M., Piéroni, L., Bruckert, E., Jardel, C., Fellahi, S., Hainque, B., et al. Systemic low-grade inflammation is related to both circulating and adipose tissue TNFalpha, leptin and IL-6 levels in obese women. Int J Obes Relat Metab Disord 28 (2004), 993–997.
106. [106] Bouloumie, A., Marumo, T., Lafontan, M., Busse, R., Leptin induces oxidative stress in human endothelial cells. FASEB J 13 (1999), 1231–1238.
107. [107] Chirumbolo, S., The role of vitamin D towards immune tolerance in white adipose tissue (WAT). Endocr Metab Immune Disord Drug Targets 15 (2015), 277–287.
108. [108] Chirumbolo, S., Vitamin D3 in cancer prevention and therapy: the nutritional issue. Horm Mol Biol Clin Investig 23 (2015), 71–78.
109. [109] Hamann, A., Matthaei, S., Regulation of energy balance by leptin. Exp Clin Endocrinol Diabetes 104 (1996), 293–300.
110. [110] Fernández-Riejos, P., Najib, S., Santos-Alvarez, J., Martín-Romero, C., Pérez-Pérez, A., González-Yanes, C., et al. Role of leptin in the activation of immune cells. Mediators Inflamm, 2010, 2010, 568343.
111. [111] Madej, T., Boguski, M.S., Bryant, S.H., Threading analysis suggests that the obese gene product may be a helical cytokine. FEBS Lett 373 (1995), 13–18.
112. [112] Tartaglia, L.A., Dembski, M., Weng, X., Deng, N., Culpepper, J., Devos, R., et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 83 (1995), 1263–1271.
113. [113] Martinez-Abundis, E., Rajapurohitam, V., Gertler, A., Karmazyn, M., Identification of functional leptin receptors expressed in ventricular mitochondria. Mol Cell Biochem 408 (2015), 155–162.
114. [114] Gao, D., Trayhurn, P., Bing, C., Macrophage-secreted factors inhibit ZAG expression and secretion by human adipocytes. Mol Cell Endocrinol 325 (2010), 135–142.
115. [115] Mracek, T., Ding, Q., Tzanavari, T., Kos, K., Pinkney, J., Wilding, J., et al. The adipokine zinc-alpha2-glycoprotein (ZAG) is downregulated with fat mass expansion in obesity. Clin Endocrinol (Oxf) 72 (2010), 334–341.
116. [116] Bing, C., Mracek, T., Gao, D., Trayhurn, P., Zinc-α2-glycoprotein: an adipokine modulator of body fat mass?. Int J Obes (Lond) 34 (2010), 1559–1565.
117. [117] Marrades, M.P., Martínez, J.A., Moreno-Aliaga, M.J., ZAG, a lipid mobilizing adipokine, is downregulated in human obesity. J Physiol Biochem 64 (2008), 61–66.
118. [118] Leal, V.O., Lobo, J.C., Stockler-Pinto, M.B., Farage, N.E., Abdalla, D.S., Leite, M. Jr., et al. Is zinc-α2-glycoprotein a cardiovascular protective factor for patients undergoing hemodialysis?. Clin Chim Acta 413 (2012), 616–619.
119. [119] Decréau, R.A., Collman, J.P., Three toxic gases meet in the mitochondria. Front Physiol, 6, 2015, 210.
120. [120] Indo, H.P., Yen, H.C., Nakanishi, I., Matsumoto, K., Tamura, M., Nagano, Y., et al. A mitochondrial superoxide theory for oxidative stress diseases and aging. J Clin Biochem Nutr 56 (2015), 1–7.
121. [121] De Haes, W., Frooninckx, L., Van Assche, R., Smolders, A., Depuydt, G., Billen, J., et al. Metformin promotes lifespan through mitohormesis via the peroxiredoxin PRDX-2. Proc Natl Acad Sci U S A 111 (2014), E2501–E2509.
122. [122] Yun, J., Finkel, T., Mitohormesis. Cell Metab 19 (2014), 757–766.
123. [123] Galluzzi, L., Kepp, O., Trojel-Hansen, C., Kroemer, G., Mitochondrial control of cellular life, stress, and death. Circ Res 111 (2012), 1198–1207.
124. [124] Wittkopp, S., Staimer, N., Tjoa, T., Gillen, D., Daher, N., Shafer, M., et al. Mitochondrial genetic background modifies the relationship between traffic-related air pollution exposure and systemic biomarkers of inflammation. PLoS One, 8, 2013, e64444.
125. [125] Senft, D., Ronai, Z.A., UPR, autophagy, and mitochondria crosstalk underlies the ER stress response. Trends Biochem Sci 40 (2015), 141–148.
126. [126] Eletto, D., Chevet, E., Argon, Y., Appenzeller-Herzog, C., Redox controls UPR to control redox. J Cell Sci 127 (2014), 3649–3658.
127. [127] Ozcan, L., Ergin, A.S., Lu, A., Chung, J., Sarkar, S., Nie, D., et al. Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metab 9 (2009), 35–51.
128. [128] Hummasti, S., Hotamisligil, G.S., Endoplasmic reticulum stress and inflammation in obesity and diabetes. Circ Res 107 (2010), 579–591.
129. [129] Pluquet, O., Pourtier, A., Abbadie, C., The unfolded protein response and cellular senescence. A review in the theme: cellular mechanisms of endoplasmic reticulum stress signaling in health and disease. Am J Physiol Cell Physiol 308 (2015), C415–C425.
130. [130] Grimble, R.F., Nutritional antioxidants and the modulation of inflammation: theory and practice. New Horiz 2 (1994), 175–185.
131. [131] Wensveen, F.M., Jelenčić, V., Valentić, S., Šestan, M., Wensveen, T.T., Theurich, S., et al. NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Nat Immunol 16 (2015), 376–385.
132. [132] Yi, Z., Bishop, G.A., Regulatory role of CD40 in obesity-induced insulin resistance. Adipocyte 4 (2014), 65–69.
133. [133] Shimano, M., Ouchi, N., Shibata, R., Ohashi, K., Pimentel, D.R., Murohara, T., et al. Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response. J Mol Cell Cardiol 49 (2010), 210–220.
134. [134] Perri, A., Vizza, D., Lupinacci, S., Toteda, G., De Amicis, F., Leone, F., et al. Adiponectin secreted by tubular renal cells during LPS exposure worsens the cellular inflammatory damage. J Nephrol 29 (2015), 185–194.
135. [135] Chirumbolo, S., The role of quercetin, flavonols and flavones in modulating inflammatory cell function. Inflamm Allergy Drug Targets 9 (2010), 263–285.
136. [136] Jung, C.H., Kim, H., Ahn, J., Jeon, T.I., Lee, D.H., Ha, T.Y., Fisetin regulates obesity by targeting mTORC1 signaling. J Nutr Biochem 24 (2013), 1547–1554.
137. [137] Guo, Z., Hu, X., Xing, Z., Xing, R., Lv, R., Cheng, X., et al. Baicalein inhibits prostate cancer cell growth and metastasis via the caveolin-1/AKT/mTOR pathway. Mol Cell Biochem 406 (2015), 111–119.
138. [138] Kim, K.M., Heo, D.R., Lee, J., Park, J.S., Baek, M.G., Yi, J.M., et al. 5,3'-Dihydroxy-6,7,4'-trimethoxyflavanone exerts its anticancer and antiangiogenesis effects through regulation of the Akt/mTOR signaling pathway in human lung cancer cells. Chem Biol Interact 225 (2015), 32–39.
139. [139] Liu, X., Wang, L., Chen, J., Ling, Q., Wang, H., Li, S., et al. Estrogen receptor β agonist enhances temozolomide sensitivity of glioma cells by inhibiting PI3 K/AKT/mTOR pathway. Mol Med Rep 11 (2015), 1516–1522.
140. [140] Nakae, J., Oki, M., Cao, Y., The FoxO transcription factors and metabolic regulation. FEBS Lett 582 (2008), 54–67.
141. [141] Ameri, K., Jahangiri, A., Rajah, A.M., Tormos, K.V., Nagarajan, R., Pekmezci, M., et al. HIGD1 A regulates oxygen consumption, ROS production, and AMPK activity during glucose deprivation to modulate cell survival and tumor growth. [E-pub ahead of print] Cell Rep, 2015 Feb 12 pii: S2211–1247(15)00033–9.
142. [142] Ameri, K., Rajah, A.M., Nguyen, V., Sanders, T.A., Jahangiri, A., Delay, M., et al. Nuclear localization of the mitochondrial factor HIGD1 A during metabolic stress. PLoS One, 8, 2013, e62758.
143. [143] Hwang, A.B., Ryu, E.A., Artan, M., Chang, H.W., Kabir, M.H., Nam, H.J., et al. Feedback regulation via AMPK and HIF-1 mediates ROS-dependent longevity in Caenorhabditis elegans. Proc Natl Acad Sci U S A 111 (2014), E4458–E4467.
144. [144] Triantafyllou, A., Liakos, P., Tsakalof, A., Chachami, G., Paraskeva, E., Molyvdas, P.A., et al. The flavonoid quercetin induces hypoxia-inducible factor-1 alpha (HIF-1 alpha) and inhibits cell proliferation by depleting intracellular iron. Free Radic Res 41 (2007), 342–356.
145. [145] Mylonis, I., Lakka, A., Tsakalof, A., Simos, G., The dietary flavonoid kaempferol effectively inhibits HIF-1 activity and hepatoma cancer cell viability under hypoxic conditions. Biochem Biophys Res Commun 398 (2010), 74–78.
146. [146] Khan, H.Y., Zubair, H., Ullah, M.F., Ahmad, A., Hadi, S.M., A prooxidant mechanism for the anticancer and chemopreventive properties of plant polyphenols. Curr Drug Targets 13 (2012), 1738–1749.
147. [147] Azam, S., Hadi, N., Khan, N.U., Hadi, S.M., Prooxidant property of green tea polyphenols epicatechin and epigallocatechin–3-gallate: implications for anticancerproperties. Toxicol In Vitro 18 (2004), 555–561.
148. [148] Mosele, J.I., Macià, A., Motilva, M.J., Metabolic and microbial modulation of the large intestine ecosystem by non-absorbed diet phenolic compounds: a review. Molecules 20 (2015), 17429–17468.
149. [149] Dueñas, M., Cueva, C., Muñoz-González, I., Jiménez-Girón, A., Sánchez-Patán, F., Santos-Buelga, C., et al. Studies on modulation of gut microbiota by wine polyphenols: from isolated cultures to omic approaches. Antioxidants (Basel) 4 (2015), 1–21.
150. [150] Hadi, S.M., Ullah, M.F., Azmi, A.S., Ahmad, A., Shamim, U., Zubair, H., et al. Resveratrol mobilizes endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage: a putative mechanism for chemoprevention of cancer. Pharm Res 27 (2010), 979–988.
151. [151] Klotz, L.O., Sánchez-Ramos, C., Prieto-Arroyo, I., Urbánek, P., Steinbrenner, H., Monsalve, M., Redox regulation of FoxO transcription factors. Redox Biol 6 (2015), 51–72.
152. [152] Murakami, A., Dose-dependent functionality and toxicity of green tea polyphenols in experimental rodents. Arch Biochem Biophys 557 (2014), 3–10.
153. [153] Frank, M., Duvezin-Caubet, S., Koob, S., Occhipinti, A., Jagasia, R., Petcherski, A., et al. Mitophagy is triggered by mild oxidative stress in a mitochondrial fission dependent manner. Biochim Biophys Acta 1823 (2012), 2297–2310.
154. [154] Murugaiyah, V., Mattson, M.P., Neurohormetic phytochemicals: an evolutionary-bioenergetic perspective. Neurochem Int 89 (2015), 271–280.
155. [155] Calabrese, V., Cornelius, C., Cuzzocrea, S., Iavicoli, I., Rizzarelli, E., Calabrese, E.J., Hormesis, cellular stress response and vitagenes as critical determinants in aging and longevity. Mol Aspects Med 32 (2011), 279–304.
156. [156] Calabrese, V., Cornelius, C., Dinkova-Kostova, A.T., Iavicoli, I., Di Paola, R., Koverech, A., et al. Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity. Biochim Biophys Acta 1822 (2012), 753–783.
157. [157] Cornelius, C., Perrotta, R., Graziano, A., Calabrese, E.J., Calabrese, V., Stress responses, vitagenes and hormesis as critical determinants in aging and longevity: mitochondria as a “chi”. Immun Ageing, 10, 2013, 15.
158. [158] Gao, M., Zhao, Z., Lv, P., Li, Y., Gao, J., Zhang, M., et al. Quantitative combination of natural anti-oxidants prevents metabolic syndrome by reducing oxidative stress. Redox Biol 6 (2015), 206–217.
159. [159] Yan, J., Zhao, Y., Suo, S., Liu, Y., Zhao, B., Green tea catechins ameliorate adipose insulin resistance by improving oxidative stress. Free Radic Biol Med 52 (2012), 1648–1657.
160. [160] Brown, L., Poudyal, H., Panchal, S.K., Functional foods as potential therapeutic options for metabolic syndrome. Obes Rev 16 (2015), 914–941.
161. [161] Gibellini, L., Bianchini, E., De Biasi, S., Nasi, M., Cossarizza, A., Pinti, M., Natural compounds modulating mitochondrial functions. Evid Based Complement Alternat Med, 2015, 2015, 527209.
162. [162] Kim, G.T., Lee, S.H., Kim, Y.M., Quercetin regulates sestrin 2-AMPK-mTOR signaling pathway and induces apoptosis via increased intracellular ROS in HCT116 colon cancer cells. J Cancer Prev 18 (2013), 264–270.
163. [163] Rendeiro, C., Rhodes, J.S., Spencer, J.P., The mechanisms of action of flavonoids in the brain: Direct versus indirect effects. Neurochem Int 89 (2015), 126–139.
164. [164] Legeay, S., Rodier, M., Fillon, L., Faure, S., Clere, N., Epigallocatechin gallate: a review of its beneficial properties to prevent metabolic syndrome. Nutrients 7 (2015), 5443–5468.
165. [165] Ríos-Hoyo, A., Cortés, M.J., Ríos-Ontiveros, H., Meaney, E., Ceballos, G., Gutiérrez-Salmeán, G., Obesity, metabolic syndrome, and dietary therapeutical approaches with a special focus on nutraceuticals (polyphenols): a mini-review. Int J Vitam Nutr Res 84 (2014), 113–123.
166. [166] Romagnolo, D.F., Selmin, O.I., Flavonoids and cancer prevention: a review of the evidence. J Nutr Gerontol Geriatr 31 (2012), 206–238.
167. [167] Marchesi, J.R., Adams, D.H., Fava, F., Hermes, G.D., Hirschfield, G.M., Hold, G., et al. The gut microbiota and host health: a new clinical frontier. Gut 65 (2016), 330–339.
168. [168] Braune, A., Blaut, M., Bacterial species involved in the conversion of dietary flavonoids in the human gut. Gut Microbes 7 (2016), 216–234.
169. [169] Blaut, M., Schoefer, L., Braune, A., Transformation of flavonoids by intestinal microorganisms. Int J Vitam Nutr Res 73 (2003), 79–87.
170. [170] Hollman, P.C., Katan, M.B., Bioavailability and health effects of dietary flavonols in man. Arch Toxicol Suppl 20 (1998), 237–248.
171. [171] Ozdal, T., Sela, D.A., Xiao, J., Boyacioglu, D., Chen, F., Capanoglu, E., The reciprocal interactions between polyphenols and gut microbiota and effects on bioaccessibility. Nutrients, 8, 2016, 78.
172. [172] Koirala, N., Thuan, N.H., Ghimire, G.P., Thang, D.V., Sohng, J.K., Methylation of flavonoids: chemical structures, bioactivities, progress and perspectives for biotechnological production. Enzyme Microb Technol 86 (2016), 103–116.
173. [173] Xiao, J., Muzashvili, T.S., Georgiev, M.I., Advances in the biotechnological glycosylation of valuable flavonoids. Biotechnol Adv 32 (2014), 1145–1156.
174. [174] Cao, H., Chen, X., Jassbi, A.R., Xiao, J., Microbial biotransformation of bioactive flavonoids. Biotechnol Adv 33 (2015), 214–223.
175. [175] Cialdella-Kam, L., Nieman, D.C., Knab, A.M., Shanely, R.A., Meaney, M.P., Jin, F., et al. A mixed flavonoid-fish oil supplement induces immune-enhancing and anti-inflammatory transcriptomic changes in adult obese and overweight women: a randomized controlled trial. Nutrients, 8, 2016, E277.
176. [176] Mullan, A., Delles, C., Ferrell, W., Mullen, W., Edwards, C.A., McColl, J.H., et al. Effects of a beverage rich in (poly)phenols on established and novel risk markers for vascular disease in medically uncomplicated overweight or obese subjects: a four week randomized placebo-controlled trial. Atherosclerosis 246 (2016), 169–176.
177. [177] Dostal, A.M., Arikawa, A., Espejo, L., Kurzer, M.S., Long-Term supplementation of green tea extract does not modify adiposity or bone mineral density in a randomized trial of overweight and obese postmenopausal women. J Nutr 146 (2016), 256–264.
178. [178] Brisighelli, F., Álvarez-Iglesias, V., Fondevila, M., Blanco-Verea, A., Carracedo, A., Pascali, V.L., et al. Uniparental markers of contemporary Italian population reveals details on its pre-Roman heritage. PLoS One, 7, 2012, e50794.
179. [179] Stover, P.J., Human nutrition and genetic variation. Food Nutr Bull 28:1 suppl (2007), S101–S115.
180. [180] Stover, P.J., Influence of human genetic variation on nutritional requirements. Am J Clin Nutr 83 (2006), 436S–442S.
181. [181] Stover, P.J., Caudill, M.A., Genetic and epigenetic contributions to human nutrition and health: managing genome-diet interactions. J Am Diet Assoc 108 (2008), 1480–1487.
182. [182] Goni, L., Cuervo, M., Milagro, F.I., Martínez, J.A., Future perspectives of personalized weight loss interventions based on nutrigenetic, epigenetic, and metagenomic data. [E-pub ahead of print] J Nutr, 2016 Mar 9.
183. [183] An, R., Liu, J., Fast-food and full-service restaurant consumption in relation to daily energy and nutrient intakes among US adult cancer survivors, 2003-2012. Nutr Health 22 (2013), 181–195.
184. [184] Mello, A.M., Paroni, G., Daragjati, J., Pilotto, A., Gastrointestinal microbiota and their contribution to healthy aging. Dig Dis 34 (2016), 194–201.
185. [185] Kashtanova, D.A., Popenko, A.S., Tkacheva, O.N., Tyakht, A.B., Alexeev, D.G., Boytsov, S.A., Association between the gut microbiota and diet: fetal life, early childhood, and further life. Nutrition 32 (2016), 620–627.
186. [186] Voreades, N., Kozil, A., Weir, T.L., Diet and the development of the human intestinal microbiome. Front Microbiol, 5, 2014, 494.
187. [187] Bienz, D., Cori, H., Hornig, D., Adequate dosing of micronutrients for different age groups in the life cycle. Food Nutr Bull 24:suppl (2003), S7–S15.
188. [188] Ost, M., Coleman, V., Kasch, J., Klaus, S., Regulation of myokine expression: role of exercise and cellular stress. Free Radic Biol Med 98 (2016), 78–89.
189. [189] Besse-Patin, A., Montastier, E., Vinel, C., Castan-Laurell, I., Louche, K., Dray, C., et al. Effect of endurance training on skeletal muscle myokine expression in obese men: identification of apelin as a novel myokine. Int J Obes (Lond) 38 (2014), 707–713.
190. [190] Piya, M.K., Harte, A.L., Sivakumar, K., Tripathi, G., Voyias, P.D., James, S., et al. The identification of irisin in human cerebrospinal fluid: Influence of adiposity, metabolic markers, and gestational diabetes. Am J Physiol Endocrinol Metab 306 (2014), E512–E518.